Life Science Zurich Graduate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life science zurich graduate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Science Zurich Graduate Today - Breaking & Trending Today

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases


Nature article presents impact and importance of epithelial barrier damage on a range of common diseases
News provided by
Share this article
STOCKHOLM, April 15, 2021 /PRNewswire/  
SciBase Holding AB ( SciBase ) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a  groundbreaking article presenting the epithelial barrier hypothesis in Nature Reviews Immunology. The article was written by Professor Cezmi Akdis at the Swiss institute of Allergy and Asthma Research (SIAF). Prof. Akdis is the key research collaborator in SciBase s product development for skin barrier assessment. The article presents the background for the steep increase in allergic diseases over the last decades, and how this increase is connected to industrialization and modern lifestyle. ....

Switzerland General , United States , Cezmi Akdis , Simon Grant , Life Science Zurich Graduate School , Allergy Research , Scibase Holding Ab , Asthma Research , Swiss Institute Of Allergy , Swiss Research Institutes For High Altitude Climate , Scibase Holding , European Academy Of Allergy , University Of Zurich , Nature Reviews , Professor Cezmi Akdis , Prof Akdis , Electrical Impedance Spectroscopy , Artificial Intelligence , Base Holding , First North Growth Market , Swiss Institute , Swiss Research Institutes , High Altitude Climate , Medicine Davos , Life Science Zurich Graduate , European Academy ,

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis


New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis
News provided by
Share this article
STOCKHOLM, April 12, 2021 /PRNewswire/
SciBase Holding AB ( SciBase ) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a new clinical study supporting SciBase s strategy to develop multiple clinical applications for the Nevisense and Nevisense Go platforms.
The study is from the Swiss institute of Allergy and Asthma Research (SIAF) and has been published in the European Journal of Allergy and Clinical Immunology (Allergy). In the study Nevisense was used to assess the skin barrier of patients with atopic dermatitis (AD) and could accurately detect signs of atopic dermatitis even on unaffected skin. The Nevisense measurement also correlated with relevant biomarkers for atopic dermatitis. ....

United States , Switzerland General , Cezmi Akdis , Simon Grant , Life Science Zurich Graduate School , Allergy Research , Asthma Research , Swiss Institute Of Allergy , Swiss Research Institutes For High Altitude Climate , Scibase Holding , Prnewswire Scibase Holding Ab , European Academy Of Allergy , University Of Zurich , European Journal , Clinical Immunology , Director Cezmi Akdis , Zurich Medical Faculty , Electrical Impedance Spectroscopy , Artificial Intelligence , Base Holding , First North Growth Market , Swiss Institute , Swiss Research Institutes , High Altitude Climate , Medicine Davos , Life Science Zurich Graduate ,